Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 323

Results For "company"

4400 News Found

ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine
Biotech | April 12, 2022

ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine

Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation


New very-high-sensitivity rapid antigen test kits hit Australian market
News | April 11, 2022

New very-high-sensitivity rapid antigen test kits hit Australian market

New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia


Crosscope collaborates with Waleed Pharmacy to enter Oman
Digitisation | April 11, 2022

Crosscope collaborates with Waleed Pharmacy to enter Oman

Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features


Intuitive launches My Intuitive App
Digitisation | April 11, 2022

Intuitive launches My Intuitive App

The app serves as a single, integrated, personalized customer platform for da Vinci surgeons


Israel’s TAU breakthrough offers new hope to help people with paralysis walk again
News | April 11, 2022

Israel’s TAU breakthrough offers new hope to help people with paralysis walk again

Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant


Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
Startup | April 11, 2022

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas


Lonza signs manufacturing deal with Asher Biotherapeutics
Biotech | April 11, 2022

Lonza signs manufacturing deal with Asher Biotherapeutics

Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein


Amyris commissions industry-leading fermentation plant
Biotech | April 11, 2022

Amyris commissions industry-leading fermentation plant

The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products


Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
Biotech | April 11, 2022

Moderna kickstarts Phase 1/2 study for influenza vaccine candidate

Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle


AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre
News | April 10, 2022

AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre

With close to 2,800 highly skilled employees, GITC is now one of the largest technology centres across the Life Sciences industry in the country